2014 -- S 2505 SUBSTITUTE A

========

LC003897/SUB A

========

     STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2014

____________

A N   A C T

RELATING TO INSURANCE

     

     Introduced By: Senators Pearson, and Picard

     Date Introduced: February 27, 2014

     Referred To: Senate Health & Human Services

     It is enacted by the General Assembly as follows:

1

     SECTION 1. Section 27-18-70 of the General Laws in Chapter 27-18 entitled "Accident

2

and Sickness Insurance Policies" is hereby amended to read as follows:

3

     27-18-70. Enteral nutrition products. -- (a) Every individual or group health insurance

4

contract, or every individual or group hospital or medical expense insurance policy, plan, or

5

group policy delivered, issued for delivery, or renewed in this state on or after January 1, 2009,

6

shall provide coverage for nonprescription enteral formulas for home use for which a physician

7

has issued a written order and which that are medically necessary for the treatment of

8

malabsorption caused by Crohn's disease, ulcerative colitis, gastroesophageal reflux, chronic

9

intestinal pseudo- obstruction, and inherited diseases of amino acids and organic acids. Coverage

10

for inherited diseases of amino acids and organic acids shall include food products modified to be

11

low protein and shall extend to all recipients regardless of age. Provided, however, that coverage

12

shall not exceed an amount of two thousand five hundred dollars ($2,500) per covered member

13

per year.

14

      (b) Benefit plans offered by an insurer may impose a copayment and/or deductibles for

15

the benefits mandated by this section, however, in no instance shall the copayment or deductible

16

amount be greater than the copayment or deductible amount imposed for prescription enteral

17

formulas or nutritional aids. Benefits for services under this chapter shall be reimbursed in

18

accordance with the respective principles and mechanisms of reimbursement for each insurer,

19

hospital, or medical service corporation, or health maintenance organization. Reimbursement

 

1

shall be provided according to the respective principles and policies of the accident and sickness

2

insurer. Nothing contained in this section precludes the accident and sickness insurer from

3

conducting managed care, medical necessity, or utilization review.

4

      (c) This section shall not apply to insurance coverage providing benefits for: (1) hospital

5

confinement indemnity; (2) dDisability income; (3) aAccident only; (4) lLong-term care; (5)

6

Medicare supplement; (6) lLimited benefit health; (7) sSpecified disease indemnity; (8) sSickness

7

or bodily injury or death by accident or both; and (9) oOther limited-benefit policies.

8

     SECTION 2. Section 27-19-61 of the General Laws in Chapter 27-19 entitled "Nonprofit

9

Hospital Service Corporations" is hereby amended to read as follows:

10

     27-19-61. Enteral nutrition products. -- (a) Every individual or group health insurance

11

contract, or every individual or group hospital or medical expense insurance policy, plan, or

12

group policy delivered, issued for delivery, or renewed in this state on or after January 1, 2009,

13

shall provide coverage for nonprescription enteral formulas for home use for which a physician

14

has issued a written order and which that are medically necessary for the treatment of

15

malabsorption caused by Crohn's disease, ulcerative colitis, gastroespphageal reflux, chronic

16

intestinal pseudo-obstruction, and inherited diseases of amino acids and organic acids. Coverage

17

for inherited diseases of amino acids and organic acids shall include food products modified to be

18

low protein and shall extend to all recipients regardless of age. Provided, however, that coverage

19

shall not exceed an amount of two thousand five hundred dollars ($2,500) per covered member

20

per year.

21

      (b) Benefit plans offered by a hospital service corporation may impose a copayment

22

and/or deductible for the benefits mandated by this section, however, in no instance shall the

23

copayment or deductible amount be greater than the copayment or deductible amount imposed for

24

prescription enteral formulas or nutritional aids. Benefits for services under this chapter shall be

25

reimbursed in accordance with the respective principles and mechanisms of reimbursement for

26

each insurer, hospital, or medical service corporation, or health maintenance organization.

27

Reimbursement shall be provided according to the respective principles and policies of the

28

accident and sickness insurer. Nothing contained in this section precludes the accident and

29

sickness insurer from conducting managed care, medical necessity, or utilization review.

30

      (c) This section shall not apply to insurance coverage providing benefits for: (1) hospital

31

confinement indemnity; (2) dDisability income; (3) aAccident only; (4) lLong-term care; (5)

32

Medicare supplement; (6) lLimited benefit health; (7) sSpecified disease indemnity; (8) sSickness

33

or bodily injury or death by accident or both; and (9) oOther limited-benefit policies.

34

     SECTION 3. Section 27-20-56 of the General Laws in Chapter 27-20 entitled "Nonprofit

 

LC003897/SUB A - Page 2 of 6

1

Medical Service Corporations" is hereby amended to read as follows:

2

     27-20-56. Enteral nutrition products. -- (a) Every individual or group health insurance

3

contract, or every individual or group hospital or medical expense insurance policy, plan, or

4

group policy delivered, issued for delivery, or renewed in this state on or after January 1, 2009,

5

shall provide coverage for nonprescription enteral formulas for home use for which a physician

6

has issued a written order and which that are medically necessary for the treatment of

7

malabsorption caused by Crohn's disease, ulcerative colitis, gastroespphageal reflux, chronic

8

intestinal pseudo-obstruction, and inherited diseases of amino acids and organic acids. Coverage

9

for inherited diseases of amino acids and organic acids shall include food products modified to be

10

low protein and shall extend to all recipients regardless of age. Provided, however, that coverage

11

shall not exceed an amount of two thousand five hundred dollars ($2,500) per covered member

12

per year.

13

      (b) Benefit plans offered by a medical service corporation may impose a copayment

14

and/or deductible for the benefits mandated by this section, however, in no instance shall the

15

copayment or deductible amount be greater than the copayment of deductible amount imposed for

16

prescription enteral formulas or nutritional aids. Benefits for services under this chapter shall be

17

reimbursed in accordance with the respective principles and mechanisms of reimbursement for

18

each insurer, hospital, or medical service corporation, or health maintenance organization.

19

Reimbursement shall be provided according to the respective principles and policies of the

20

accident and sickness insurer. Nothing contained in this section precludes the accident and

21

sickness insurer from conducting managed care, medical necessity, or utilization review.

22

      (c) This section shall not apply to insurance coverage providing benefits for: (1) hospital

23

confinement indemnity; (2) dDisability income; (3) aAccident only; (4) lLong-term care; (5)

24

Medicare supplement; (6) lLimited benefit health; (7) sSpecified disease indemnity; (8) sSickness

25

or bodily injury or death by accident or both; and (9) oOther limited-benefit policies.

26

     SECTION 4. Section 27-41-74 of the General Laws in Chapter 27-41 entitled "Health

27

Maintenance Organizations" is hereby amended to read as follows:

28

     27-41-74. Enteral nutrition products. -- (a) Every individual or group health insurance

29

contract, or every individual or group hospital or medical expense insurance policy, plan, or

30

group policy delivered, issued for delivery, or renewed in this state on or after January 1, 2009,

31

shall provide coverage for nonprescription enteral formulas for home use for which a physician

32

has issued a written order and which that are medically necessary for the treatment of

33

malabsorption caused by Crohn's disease, ulcerative colitis, gastroespphageal reflux, chronic

34

intestinal pseudo-obstruction, and inherited diseases of amino acids and organic acids. Coverage

 

LC003897/SUB A - Page 3 of 6

1

for inherited diseases of amino acids and organic acids shall include food products modified to be

2

low protein and shall extend to all recipients regardless of age. Provided, however, that coverage

3

shall not exceed an amount of two thousand five hundred dollars ($2,500) per covered member

4

per year.

5

      (b) Benefit plans offered by a health maintenance organization may impose a copayment

6

and/or deductible for the benefits mandated by this section, however, in no instance shall the

7

copayment or deductible amount be greater than the copayment of deductible amount imposed for

8

prescription enteral formulas or nutritional aids. Benefits for services under this chapter shall be

9

reimbursed in accordance with the respective principles and mechanisms of reimbursement for

10

each insurer, hospital, or medical service corporation, or health maintenance organization.

11

Reimbursement shall be provided according to the respective principles and policies of the

12

accident and sickness insurer. Nothing contained in this section precludes the accident and

13

sickness insurer from conducting managed care, medical necessity, or utilization review.

14

      (c) This section shall not apply to insurance coverage providing benefits for: (1)

15

hHospital confinement indemnity; (2) dDisability income; (3) aAccident only; (4) lLong-term

16

care; (5) Medicare supplement; (6) lLimited benefit health; (7) sSpecified disease indemnity; (8)

17

sSickness or bodily injury or death by accident or both; and (9) oOther limited-benefit policies.

18

     SECTION 5. Section 40-6-3.12 of the General Laws in Chapter 40-6 entitled "Public

19

Assistance Act" is hereby amended to read as follows:

20

     40-6-3.12. Enteral nutrition products. -- (a) As used in this section:

21

      (1) "Enteral nutrition" means a supplemental feeding that is provided via the

22

gastrointestinal tract by mouth (orally), or through a tube, catheter, or stoma that delivers

23

nutrients distal to the oral cavity.

24

      (2) "Nutritional risk" means actual or potential for developing malnutrition, as evidenced

25

by clinical indicators, the presence of chronic disease, or increased metabolic requirements due to

26

impaired ability to ingest or absorb food adequately.

27

      (b) The department shall provide for vendor payment of enteral nutrition products in

28

accordance with rules and regulations of the department, when determined to be medically

29

necessary on an individual, case-by-case basis and ordered by a physician in accordance with

30

Rhode Island department of health form(s) on enteral nutrition products. Provided, however, that

31

coverage shall not exceed an amount of two thousand five hundred dollars ($2,500) per individual

32

per year.

33

     (c) Protocols for the use of enteral nutrition as a medically necessary treatment for

34

malabsorption caused by Crohn’s disease, ulcerative colitis, gastroesophageal reflux, chronic

 

LC003897/SUB A - Page 4 of 6

1

intestinal pseudo-obstruction, and inherited diseases of amino acids and organic acids may be

2

developed by the director. The determination of medical necessity for enteral nutrition products

3

shall be based upon a combination of clinical data and the presence of indicators that would affect

4

the relative risks and benefits of the products including, but not limited to:

5

      (1) Enteral nutrition, whether orally or by tube feeding, is used as a therapeutic regimen

6

to prevent serious disability or death in a person with a medically diagnosed condition that

7

precludes the full use of regular food.

8

      (2) The person presents clinical signs and symptoms of impaired digestion

9

malabsorption, or nutritional risk, as indicated by the following anthropometric measures:

10

      (i) Weight loss that presents actual or potential for developing, malnutrition as follows:

11

      (A) In adults, showing involuntary or acute weight loss of greater than, or equal to, ten

12

percent (10%) of usual body weight during a three (3) to six- (6) month (6) period, or body mass

13

index (bmi) below 18.5 kg/m2;

14

      (B) In neonates, infants and children, showing:

15

      (I) Very low birth weight (lbw), even in the absence of gastrointestinal, pulmonary, or

16

cardiac disorders;

17

      (II) A lack of weight gain, or weight gain less than two (2) standard deviations below the

18

age appropriate mean in a one month period for children under six (6) months, or two (2) month

19

period for children aged six (6) to twelve (12) months;

20

      (III) No weight gain or abnormally slow rate of gain for three (3) months for children

21

older than one year, or documented weight loss that does not reverse promptly with instruction in

22

appropriate diet for age; or

23

      (IV) Weight for height less than the tenth (10th) percentile; and

24

      (ii) Abnormal laboratory test pertinent to the diagnosis.

25

      (3) The risk factors for actual or potential malnutrition have been identified and

26

documented. Such risk factors include, but are not limited to, the following:

27

      (i) Anatomic structures of the gastrointestinal tract that impair digestion and absorption;

28

      (ii) Neurological disorders that impair swallowing or chewing;

29

      (iii) Diagnosis of inborn errors of metabolism that require medically necessary formula

30

used for specific metabolic conditions and food products modified low in protein (for example,

31

phenylketonuria (pku) tyrosinemia, homocystinuria, maple syrup urine disease, propionic aciduria

32

and methylmalonic aciduria);

33

      (iv) Prolonged nutrient losses due to malabsorption syndromes or short-bowel

34

syndromes, diabetes, celiac disease, chronic pancreatitis, renal dialysis, draining abscess or

 

LC003897/SUB A - Page 5 of 6

1

wounds, etc.;

2

      (v) Treatment with anti-nutrient or catabolic properties (for example, anti-tumor

3

treatments, corticosteroids, immunosuppressant, etc.);

4

      (vi) Increased metabolic and/or caloric needs due to excessive burns, infection, trauma,

5

prolonged fever, hyperthyroidism, or illnesses that impair caloric intake and/or retention; or

6

      (vii) A failure-to-thrive diagnosis that increases caloric needs while impairing caloric

7

intake and/or retention.

8

      (4) A comprehensive medical history and a physical examination have been conducted to

9

detect factors contributing to nutritional risk.

10

      (5) Enteral nutrition is indicated as the primary source of nutritional support essential for

11

the management of risk factors that impair digestion or malabsorption, and for the management of

12

surgical preparation or postoperative care.

13

      (6) A written plan of care has been developed for regular monitoring of signs and

14

symptoms to detect improvement in the person's condition. Nutritional status should be monitored

15

regularly;

16

      (i) For improvements in anthropometric measures;

17

      (ii) For improvements in laboratory test indicators; and

18

      (iii) In children, to assess growth and weight for height.

19

      (d) Enteral nutrition products shall not be considered medically necessary under certain

20

circumstances including, but not limited to, the following:

21

      (1) A medical history and physical examination have been performed and other possible

22

alternatives have been identified to minimize nutritional risk.

23

      (2) The person is underweight, but has the ability to meet nutritional needs through the

24

use of regular food consumption.

25

      (3) Enteral products are used as supplements to a normal or regular diet in a person

26

showing no clinical indicators of nutritional risk.

27

      (4) The person has food allergies, lactose intolerance or dental problems, but has the

28

ability to meet his or her nutritional requirements through an alternative food source.

29

      (5) Enteral products are to be used for dieting or a weight-loss program.

30

      (6) No medical history or physical examination has been taken and there is no

31

documentation that supports the need for enteral nutrition products.

32

     SECTION 6. This act shall take effect upon passage.

========

LC003897/SUB A

========

 

LC003897/SUB A - Page 6 of 6

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

A N   A C T

RELATING TO INSURANCE

***

1

     This act would require insurance coverage of formula and other prescribed food for all

2

patients regardless of age, and would also abolish the mandated cap on coverage.

3

     This act would take effect upon passage.

========

LC003897/SUB A

========

 

LC003897/SUB A - Page 7 of 6